kras mutation and glutathion Kras: structure activation. (A) The gene. Mutations in human KRAS-targeted therapies in cancer: novel
KRAS targeted therapies in cancer: novel approaches and overcoming resistance BMJ Oncology Promising direction for the treatment of pancreatic cancers driven by KRAS mutation Der Lab Frontiers Targeting KRAS: The Elephant in the Room of Epithelial Cancers Targeting mutated GTPase KRAS in tumor therapies ScienceDirect The KRAS G12D mutation induces metabolic vulnerability in B cell acute lymphoblastic leukemia ScienceDirect
Pay in 4 interest-free payments of $6.86 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1




